{"cmr":"ca-cm-kg/TSXV/HEM","since":null,"total":14,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ca-cm-kg/TSXV/HEM","date":"2026-10-07","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=321934&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Fc9WiB6qDknLu-un9FnyEfCZvil54g_5_fIg8viZcB5DNvRjbQDEclrCzcyMee62Ek2iZvGCz9vapMZQnGc5CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2026-10-07","event_type":"newswire_release","title":"Hemostemix Announces Full LARTA Approval ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/317952/Hemostemix-Announces-Full-LARTA-Approval-Manufacturing-Progress-and-Financing-Update?lang=fr","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"AnpYrSTblRchA1sBRYf2xuqGtdXQR56X6x2JtINZyMN_27SjdYntYJElEpteyUShRrSAR-t_Ozlt83QhTkyQDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2026-10-07","event_type":"newswire_release","title":"Hemostemix Announces Full LARTA Approval, Manufacturing Progress and Financing Update","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/317952/Hemostemix-Announces-Full-LARTA-Approval-Manufacturing-Progress-and-Financing-Update","read_by":"Tavily search (newsfilecorp.com) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"sx7aqbk4WTzh21BMvPzcjCnyxwsKfNFzM7a6vSLqxeXR9eFQ63xCQoGmbkTmQ6sv7icVeiPYgOidEw0GyJjGAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2026-08-20","event_type":"newswire_release","title":"Hemostemix Commercializes Its Vascular Dementia Clinical Trial of ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/310607/Hemostemix-Commercializes-Its-Vascular-Dementia-Clinical-Trial-of-VesCellTM-Under-LARTA","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5DscTu0mdNARemksHOLd5J4DiBQo9YWiVHh3BVFWcU0IZll1mWSLKnbSTrxbMJwVxJHulkI7VxjD3U9YIka1CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2026-08-12","event_type":"newswire_release","title":"Dr. Ernst von Schwarz, Principal Investigator of Hemostemix VesCell ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/309315/Dr.-Ernst-von-Schwarz-Principal-Investigator-of-Hemostemix-VesCellTM-Longevity-Clinical-Trial","read_by":"Tavily search (newsfilecorp.com) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5DFJKVWw6zda0Fph68fI_KmQPc9-4T14IkNyLTaVT-6QlQyQ_lPXM7awWVQZEH-9DAgKjiN79KR-Oy7eIhxmDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2026-07-30","event_type":"newswire_release","title":"Hemostemix Closes Second Tranche of Private Placement and Obtains Extension to August 14, 2026","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/307406/Hemostemix-Closes-Second-Tranche-of-Private-Placement-and-Obtains-Extension-to-August-14-2026","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"bOj0GlssopK6mulC8ncsroczN8yDcRFWgbEmwPok9F3ou81f65lYzNDXrYGSYM5M2aVOR03FW2j2rS1azH07AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2026-07-28","event_type":"newswire_release","title":"Hemostemix' Longevity Phase I Clinical Trial Leveraging VesCell(TM)'s Excellent Results","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/306926/Hemostemix-Longevity-Phase-I-Clinical-Trial-Leveraging-VesCellTMs-Excellent-Results","read_by":"Tavily search (newsfilecorp.com) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"MJjBKLDl7flQR1ErzJE3hwC64HNPPZPhPglbiFbgLU7Tn2KPV-FQ3jUNeV3S63gDIJj8wWfXPNVJ9KUOU4K7CQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2026-07-08","event_type":"newswire_release","title":"Commercialization Application Filed by Hemostemix for the Treatment of Vascular Dementia, Angina and Pain","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/304397/Commercialization-Application-Filed-by-Hemostemix-for-the-Treatment-of-Vascular-Dementia-Angina-and-Pain","read_by":"Tavily search (newsfilecorp.com) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"joSACrXT1DkEBsInV-O_hTjnCr0NqVkJboaODv5s2dAStKKQspal764ppFGM8W33t4_ay0BLDTYXoJjMT2sGBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2026-03-31","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=315512&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"s4tdiQK4mDzOFAYP5thM9_6-aPL-FYhs8J-r632cDb0mRbhUjxjBev1S5pr-baEFndKCazQciLu0p4GkuobzDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2026-01-16","event_type":"newswire_release","title":"Hemostemix Receives FDA Support for Its Basket Protocol Approach","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/280644/Hemostemix-Receives-FDA-Support-for-Its-Basket-Protocol-Approach","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"yrMEbRVzVwHstJ-PB10eS9EMoU1PACzHIXOtvnbARn0sMn5Ld7Ub5SmA00uT94nMpXVkDvIeB32VI8uqRSxkAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2025-12-18","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=308378&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xRg13_ZY_d7qVucYKDeLeHLt5TmA_UVOWJdaDOnjZ8xKHnGmcPXOozaBf_LMFMEvkg57fsaU7yP60zulhTaDAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2025-12-10","event_type":"newswire_release","title":"Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/277583/Hemostemix-Inc.-Announces-FDA-PreIND-Meeting-and-NBPP-of-960000","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Bm1V2kyIDVvjpn337nUt8GrhgGsYl_vqXpSbYUDhTFoEhJJo3KdzaJYE77KB-_lL_8mJHXXUWfIELqQtg0EyAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2025-11-25","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=306979&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4OY_9-YA_PlfGM8w80MVo6i_zjGtaDpK405htg-n_bcanJr2avGQV2s4tcZd4qCpU9CnpM0gzkArccoMiEfvDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/HEM","date":"2025-09-11","event_type":"exchange_bulletin","title":"TSXV bulletin: SHARES FOR DEBT (Material Changes)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=302136&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Material Changes / SHARES FOR DEBT","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"IbiSfhI7-G3LHVMkLfXPGyzXfY1u6Oj4OG4k2wowQx2vb671QWAW486QBzHC6FRKvpcMxo8cN74x6Wh8jWtmCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}